Polyrizon Ltd. ( ($PLRZ) ) has issued an update. On December 11, 2025, Polyrizon Ltd. announced promising results from preclinical studies of its ...

Superior Mucoadhesion may potentially Translate into More Reliable Opioid Overdose Reversal in Real-World Emergencies Ra’anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (PLRZ) ...

RA’ANANA, ISRAEL - Polyrizon Ltd. (NASDAQ:PLRZ) announced Thursday that its intranasal naloxone hydrogel formulation demonstrated favorable permeation kinetics in preclinical testing, complementing ...

Ra’anana, Israel, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today ...

(RTTNews) - Polyrizon Ltd. (PLRZ), a biotechnology company developing intranasal products, reported encouraging preclinical findings showing that its proprietary Trap and Target naloxone hydrogel ...

What you need to know: As the state tracks nearly 400,000 overdoses reversed through the Naloxone Distribution Project, the ...

Though many Illinois libraries already have supplies of medications that can reverse opioid overdoses, a new state law will ...